Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 0.3500
+0.0400 (12.90%)
Sep 4, 2026, 11:29 AM CET
STO:MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 74.63M SEK in the quarter ending June 30, 2026, with 35.11% growth. This brings the company's revenue in the last twelve months to 302.62M, down -1.12% year-over-year. In the year 2025, Magle Chemoswed Holding AB had annual revenue of 278.73M with 8.80% growth.
Revenue (ttm)
302.62M
Revenue Growth
-1.12%
P/S Ratio
0.03
Revenue / Employee
1.84M
Employees
150
Market Cap
9.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 278.73M | 22.55M | 8.80% |
| Dec 31, 2024 | 256.18M | 73.00M | 39.85% |
| Dec 31, 2023 | 183.19M | 26.81M | 17.15% |
| Dec 31, 2022 | 156.38M | 11.89M | 8.23% |
| Dec 31, 2021 | 144.49M | -1.76M | -1.20% |
| Dec 31, 2020 | 146.25M | 6.76M | 4.85% |
| Dec 31, 2019 | 139.49M | 18.70M | 15.48% |
| Dec 31, 2018 | 120.79M | -5.67M | -4.48% |
| Dec 31, 2017 | 126.46M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ExpreS2ion Biotech Holding AB | 24.25M |
| Fluicell AB | 22.19M |
| AcouSort AB | 9.31M |
| OncoZenge AB | 5.97M |
| Biosergen AB | 2.09M |
| NanoEcho AB | 1.13M |
| Alligator Bioscience AB | 681.00K |
| Pila Pharma AB | 275.74K |
Magle Chemoswed Holding AB News
- 22 days ago - Magle Chemoswed Holding AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Magle Chemoswed Holding AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Magle Chemoswed Holding AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Magle Chemoswed Holding AB Annual report: Q4 2025 - Filings
- 9 months ago - Magle Chemoswed Holding AB Quarterly report: Q3 2025 - Filings